Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-02-07 | New | $1,636,582 | $1,636,582 | Equity Only | 06b | SEC link |
| 2022-12-23 | Amended | $7,711,958 | $2,715,323 | Debt Only | 06b | SEC link |
| 2021-12-22 | Amended | $4,996,635 | $4,269,766 | Debt Only | 06b | SEC link |
| 2021-04-02 | New | $726,869 | $726,869 | Equity Only | 06b | SEC link |
| 2020-06-23 | New | $500,999 | $500,999 | Equity Only | 06b | SEC link |
| 2020-03-19 | Amended | $820,000 | $755,000 | Debt Only | 06b | SEC link |
| 2019-11-22 | New | $65,000 | $65,000 | Debt Only | 06b | SEC link |
| 2019-08-08 | Amended | $380,000 | $325,000 | Debt Only | 06b | SEC link |
| 2019-05-30 | New | $55,000 | $55,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Cuong Do | Director, Executive |
| Paul Hallenbeck | Director, Executive |
| James Hussey | Director, Executive |
| Mark Kerschner | Director |